Cargando…
How I treat microangiopathic hemolytic anemia in patients with cancer
Microangiopathic hemolytic anemia (MAHA) with thrombocytopenia, suggests a thrombotic microangiopathy (TMA), linked with thrombus formation affecting small or larger vessels. In cancer patients, it may be directly related to the underlying malignancy (initial presentation or progressive disease), to...
Autores principales: | Thomas, M. R., Scully, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555418/ https://www.ncbi.nlm.nih.gov/pubmed/33512445 http://dx.doi.org/10.1182/blood.2019003810 |
Ejemplares similares
-
How I treat older patients with DLBCL in the frontline setting
por: Lugtenburg, Pieternella J., et al.
Publicado: (2023) -
How I treat AML incorporating the updated classifications and guidelines
por: El Chaer, Firas, et al.
Publicado: (2023) -
How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023) -
How I Treat Acute and Persistent Sickle Cell Pain
por: Ballas, Samir K.
Publicado: (2020) -
How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023)